Table of Content

Table of Content

Chapter 1 Methodology and Scope
1.1 Market segmentation & scope
1.2 Market definition
1.3 Information procurement
1.3.1 Purchased database
1.3.2 GVR’s internal database
1.3.3 Secondary sources & third party perspectives
1.3.4 Primary research
1.4 Information analysis
1.4.1 Data analysis models
1.5 Market formulation & data visualization
1.6 Data validation & publishing
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights
Chapter 3 Hunter Syndrome Treatment Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Ancillary Market Outlook
3.2 Penetration and Growth Prospect Mapping
3.2.1 User perspective analysis
3.2.1.1 Consumer behavior analysis
3.2.1.2 Market influencer analysis
3.3 Regulatory Framework
3.3.1 Reimbursement framework
3.3.2 Standards and compliances
3.4 Market Dynamics
3.4.1 Market driver analysis
3.4.1.1 Robust Pipeline & intorduction of novel therapies
3.4.1.2 Increasing government initatives
3.4.2 Market Restraint Analysis
3.4.2.1 High treatment cost
3.4.3 Industry challenges
3.5 Hunter Syndrome Treatment Market Analysis Tools
3.5.1 Industry analysis - Porter’s
3.5.1.1 Supplier Power
3.5.1.2 Buyer Power
3.5.1.3 Substitution Threat
3.5.1.4 Threat from new entrants
3.5.1.5 Competitive Rivalry
3.5.2 PESTEL Analysis
3.5.2.1 Political Landscape
3.5.2.2 Environmental Landscape
3.5.2.3 Social landscape
3.5.2.4 Technology landscape
3.5.2.5 Legal Landscape
3.5.3 Major deals and strategic alliances analysis
3.5.3.1 Joint ventures
3.5.3.2 Mergers and acquisitions
3.5.3.3 Licensing and partnership
3.5.3.4 Technology collaborations
3.5.3.5 Strategic Divestments
3.5.4 Market entry strategies
Chapter 4 Hunter Syndrome Treatment Market - Competitive Analysis
4.1 Recent Developments & Impact Analysis, by Key Market Participants
4.2 Vendor Landscape
4.2.1 List of key distributors and channel partners
4.3 Public Companies
4.3.1 Key company market share analysis, 2018
4.4 Private Companies
4.4.1 List of key emerging companies
4.4.2 Regional network map
4.4.3 Company market position analysis
Chapter 5 Hunter Syndrome Treatment Market: Treatment Estimates And Trend Analysis
5.1 Definition & Scope
5.2 Treatment Market Share Analysis, 2018 & 2026
5.3 Segment Dashboard
5.4 Global Hunter Syndrome Treatment Market, by Treatment, 2015 to 2026
5.5 Market Size & Forecasts and Trend Analyses, 2015 to 2026
5.5.1 Enzyme Replacement Therapy (ERT)
5.5.1.1 Market Estimates and Forecasts, 2015 to 2026 (USD Million)
5.5.2 Hematopoietic Stem Cell Transplant (HSCT)
5.5.2.1 Market Estimates and Forecasts, 2015 to 2026 (USD Million)
5.5.3 Others
5.5.3.1 Market Estimates and Forecasts, 2015 to 2026 (USD Million)
Chapter 6 Hunter Syndrome Treatment Market: Regional Estimates & Trend Analysis
6.1 Regional Market Snapshot
6.2 Regional Market Share and Leading Players, 2018
6.2.1 North America
6.2.2 Europe
6.2.3 Latin America
6.2.4 Asia Pacific
6.2.5 Middle East & Africa
6.3 Market Share Analysis by Country, 2018
6.3.1 North America
6.3.1.1 U.S.
6.3.1.2 Canada
6.3.2 Europe
6.3.2.1 UK
6.3.2.2 Germany
6.3.2.3 Spain
6.3.2.4 France
6.3.2.5 Italy
6.3.2.6 Russia
6.3.3 Latin America
6.3.3.1 Brazil
6.3.3.2 Mexico
6.3.3.3 Argentina
6.3.4 Asia Pacific
6.3.4.1 Japan
6.3.4.2 China
6.3.4.3 India
6.3.4.4 South Korea
6.3.4.5 Australia
6.3.4.6 Singapore
6.3.5 Middle East & Africa
6.3.5.1 South Africa
6.3.5.2 Saudi Arabia
6.3.5.3 UAE
6.4 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
6.4.1 North America
6.4.2 Europe
6.4.3 Latin America
6.4.4 Asia Pacific
6.4.5 Middle East & Africa
6.5 Market Size & Forecasts, And Trend Analysis, 2018 To 2026
6.5.1 North America
6.5.1.1 Market Size & Forecasts and Trend Analysis, 2015 To 2026 (USD Million)
6.5.1.2 U.S.
6.5.1.2.1 Market Size & Forecasts and Trend Analysis, By Treatament, 2015 To 2026 (USD Million)
6.5.1.3 Canada
6.5.1.3.1 Market Size & Forecasts and Trend Analysis, By Treatament, 2015 To 2026 (USD Million)
6.5.2 Europe
6.5.2.1 Market Size & Forecasts and Trend Analysis, 2015 To 2026 (USD Million)
6.5.2.2 UK
6.5.2.2.1 Market Size & Forecasts and Trend Analysis, By Treatament, 2015 To 2026 (USD Million)
6.5.2.3 Germany
6.5.2.3.1 Market Size & Forecasts and Trend Analysis, By Treatament, 2015 To 2026 (USD Million)
6.5.2.4 Spain
6.5.2.4.1 Market Size & Forecasts and Trend Analysis, By Treatament, 2015 To 2026 (USD Million)
6.5.2.5 France
6.5.2.5.1 Market Size & Forecasts and Trend Analysis, By Treatament, 2015 To 2026 (USD Million)
6.5.2.6 Italy
6.5.2.6.1 Market Size & Forecasts and Trend Analysis, By Treatament, 2015 To 2026 (USD Million)
6.5.2.7 Russia
6.5.2.7.1 Market Size & Forecasts and Trend Analysis, By Treatament, 2015 To 2026 (USD Million)
6.5.3 Latin America
6.5.3.1 Market Size & Forecasts and Trend Analysis, 2015 To 2026 (USD Million)
6.5.3.2 Brazil
6.5.3.1.1 Market Size & Forecasts and Trend Analysis, By Treatament, 2015 To 2026 (USD Million)
6.5.3.2 Mexico
6.5.3.2.1 Market Size & Forecasts and Trend Analysis, By Treatament, 2015 To 2026 (USD Million)
6.5.3.3 Argentina
6.5.3.3.1 Market Size & Forecasts and Trend Analysis, By Treatament, 2015 To 2026 (USD Million)
6.5.4 Asia Pacific
6.5.4.1 Market Size & Forecasts and Trend Analysis, 2015 To 2026 (USD Million)
6.5.4.2 Japan
6.5.4.2.1 Market Size & Forecasts and Trend Analysis, By Treatament, 2015 To 2026 (USD Million)
6.5.4.3 China
6.5.4.3.1 Market Size & Forecasts and Trend Analysis, By Treatament, 2015 To 2026 (USD Million)
6.5.4.4 India
6.5.4.4.1 Market Size & Forecasts and Trend Analysis, By Treatament, 2015 To 2026 (USD Million)
6.5.4.5 South Korea
6.5.4.5.1 Market Size & Forecasts and Trend Analysis, By Treatament, 2015 To 2026 (USD Million)
6.5.4.6 Australia
6.5.4.6.1 Market Size & Forecasts and Trend Analysis, By Treatament, 2015 To 2026 (USD Million)
6.5.4.7 Singapore
6.5.4.7.1 Market Size & Forecasts and Trend Analysis, By Treatament, 2015 To 2026 (USD Million)
6.5.5 Middle East & Africa
6.5.5.1 Market Size & Forecasts and Trend Analysis, 2015 To 2026 (USD Million)
6.5.5.2 South Africa
6.5.5.2.1 Market Size & Forecasts and Trend Analysis, By Treatament, 2015 To 2026 (USD Million)
6.5.5.3 Saudi Arabia
6.5.5.3.1 Market Size & Forecasts and Trend Analysis, By Treatament, 2015 To 2026 (USD Million)
6.5.5.4 UAE
6.5.5.4.1 Market Size & Forecasts and Trend Analysis, By Treatament, 2015 To 2026 (USD Million)
Chapter 7 COMPANY PROFILE
7.1 Company Profiles
7.1.1 Takeda Pharmaceutical Company
7.1.1.1 Company overview
7.1.1.2 Financial Performance
7.1.1.3 Product benchmarking
7.1.1.4 Strategic initiatives
7.1.2 GC Pharma
7.1.2.1 Company overview
7.1.2.2 Financial Performance
7.1.2.3 Product benchmarking
7.1.2.4 Strategic initiatives
7.1.3 JCR Pharmaceuticals Co Ltd.
7.1.3.1 Company overview
7.1.3.2 Financial Performance
7.1.3.3 Product benchmarking
7.1.3.4 Strategic initiatives
7.1.4 RegenxBio Inc.
7.1.4.1 Company overview
7.1.4.2 Financial Performance
7.1.4.3 Product benchmarking
7.1.4.4 Strategic initiatives
7.1.5 Sangamo Therapeutics, Inc.
7.1.5.1 Company overview
7.1.5.2 Financial Performance
7.1.5.3 Product benchmarking
7.1.5.4 Strategic initiatives
7.1.6 ArmaGen Inc.
7.1.6.1 Company overview
7.1.6.2 Financial Performance
7.1.6.3 Product benchmarking
7.1.6.4 Strategic initiatives
7.1.7 Inventiva S.A.
7.1.7.1 Company overview
7.1.7.2 Financial Performance
7.1.7.3 Product benchmarking
7.1.7.4 Strategic initiatives
7.1.8 Denali Therapeutics Inc.
7.1.8.1 Company overview
7.1.8.2 Financial Performance
7.1.8.3 Product benchmarking
7.1.9 Bioasis Technologies Inc.
7.1.9.1 Company overview
7.1.9.2 Financial Performance
7.1.9.3 Product benchmarking
7.1.9.4 Strategic initiatives



List of Tables



Table 1 List of key distributors and channel partners
Table 2 List of key emerging companies’/technology disruptors/innovators
Table 3 North America Hunter syndrome treatment market, by country, 2015 - 2026 (USD Million)
Table 4 North America Hunter syndrome treatment market, by treatment, 2015 - 2026 (USD Million)
Table 5 U.S. Hunter syndrome treatment market, by treatment, 2015 - 2026 (USD Million)
Table 6 Canada Hunter syndrome treatment market, by treatment, 2015 - 2026 (USD Million)
Table 7 Europe Hunter syndrome treatment market, by country, 2015 - 2026 (USD Million)
Table 8 Europe Hunter syndrome treatment market, by treatment, 2015 - 2026 (USD Million)
Table 9 Germany Hunter syndrome treatment market, by treatment, 2015 - 2026 (USD Million)
Table 10 UK Hunter syndrome treatment market, by treatment, 2015 - 2026 (USD Million)
Table 11 Spain Hunter syndrome treatment market, by treatment, 2015 - 2026 (USD Million)
Table 12 France Hunter syndrome treatment market, by treatment, 2015 - 2026 (USD Million)
Table 13 Italy Hunter syndrome treatment market, by treatment, 2015 - 2026 (USD Million)
Table 14 Russia Hunter syndrome treatment market, by treatment, 2015 - 2026 (USD Million)
Table 15 Asia Pacific Hunter syndrome treatment market, by Country, 2015 - 2026 (USD Million)
Table 16 Asia Pacific Hunter syndrome treatment market, by treatment, 2015 - 2026 (USD Million)
Table 17 Japan Hunter syndrome treatment market, by treatment, 2015 - 2026 (USD Million)
Table 18 China Hunter syndrome treatment market, by treatment, 2015 - 2026 (USD Million)
Table 19 India Hunter syndrome treatment market, by treatment, 2015 - 2026 (USD Million)
Table 20 South Korea Hunter syndrome treatment market, by treatment, 2015 - 2026 (USD Million)
Table 21 Australia Hunter syndrome treatment market, by treatment, 2015 - 2026 (USD Million)
Table 22 Singapore Hunter syndrome treatment market, by treatment, 2015 - 2026 (USD Million)
Table 23 Latin America Hunter syndrome treatment market, by country, 2015 - 2026 (USD Million)
Table 24 Latin America Hunter syndrome treatment market, by treatment, 2015 - 2026 (USD Million)
Table 25 Brazil Hunter syndrome treatment market, by treatment, 2015 - 2026 (USD Million)
Table 26 Mexico Hunter syndrome treatment market, by treatment, 2015 - 2026 (USD Million)
Table 27 Argentina Hunter syndrome treatment market, by treatment, 2015 - 2026 (USD Million)
Table 28 MEA Hunter syndrome treatment market, by country, 2015 - 2026 (USD Million)
Table 29 MEA Hunter syndrome treatment market, by treatment, 2015 - 2026 (USD Million)
Table 30 South Africa Hunter syndrome treatment market, by treatment, 2015 - 2026 (USD Million)
Table 31 Saudi Arabia Hunter syndrome treatment market, by treatment, 2015 - 2026 (USD Million)
Table 32 UAE Hunter syndrome treatment market, by treatment, 2015 - 2026 (USD Million)